Placebo-Controlled Trials, Ethics of

Publication date

2015-03-26

Authors

van der Graaf, RiekeORCID 0000-0003-4907-7044ISNI 0000000389642183
Rid, Annette

Editors

Wright, James D.

Advisors

Supervisors

Document Type

Entry

Collections

Open Access logo

License

taverne

Abstract

There are often good scientific and ethical reasons for using placebo controls in clinical trials. At the same time placebo use is controversial, especially when an established effective treatment is being withheld from the control group. This article gives an overview of the key ethical positions in the controversy around placebo-controlled trials. While some argue that placebo controls can only be used when withholding or delaying an established effective treatment poses no or negligible risks to participants, others hold that the risks should be low or acceptable in light of the social value of the knowledge to be gained from the research. The article also describes different positions on placebo use in trials in low- and middle-income countries where study participants may not have had access to an established effective treatment outside the trial.

Keywords

Clinical equipoise, Clinical research ethics, Clinical trial design, Clinical trials, Human subjects research, Investigator obligations, LMICs (low- and middle-income countries), Placebo, Placebo-controlled trials, Randomized clinical trials, Risks, Therapeutic obligations, Taverne, General Social Sciences

Citation

van der Graaf, R & Rid, A 2015, Placebo-Controlled Trials, Ethics of. in J D Wright (ed.), International Encyclopedia of the Social & Behavioral Sciences. 2 edn, Elsevier, London, pp. 164-173. https://doi.org/10.1016/B978-0-08-097086-8.11011-6